Matrix Metalloproteinase 2 and 9 Enzymatic Activities are Selectively Increased in the Myocardium of Chronic Chagas Disease Cardiomyopathy Patients: Role of TIMPs

被引:11
作者
Baron, Monique Andrade [1 ,2 ,3 ]
Pinto Ferreira, Ludmila Rodrigues [1 ,2 ,3 ,4 ,10 ]
Teixeira, Priscila Camillo [1 ,2 ,3 ,8 ]
Soares Moretti, Ana Iochabel [5 ]
Barros Santos, Ronaldo Honorato [6 ]
Frade, Amanda Farage [1 ,2 ,3 ,9 ]
Kuramoto, Andreia [1 ,3 ]
Debbas, Victor [4 ]
Benvenuti, Luiz Alberto [6 ]
Gaiotto, Fabio Antonio [5 ]
Bacal, Fernando [5 ]
Pomerantzeff, Pablo [5 ]
Chevillard, Christophe [7 ]
Kalil, Jorge [2 ,3 ]
Cunha-Neto, Edecio [1 ,2 ,3 ]
机构
[1] Univ Sao Paulo, Heart Inst InCor, Sch Med, Lab Immunol, Sao Paulo, Brazil
[2] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil
[3] Inst Nacionais Ciencia & Tecnol INCT, Inst Invest Immunol, Sao Paulo, Brazil
[4] Univ Santo Amaro, Dept Bioengn, Sao Paulo, Brazil
[5] Univ Sao Paulo, Heart Inst InCor, Sch Med, Vasc Biol Lab, Sao Paulo, Brazil
[6] Univ Sao Paulo, Heart Inst InCor, Sch Med, Div Transplantat, Sao Paulo, Brazil
[7] Aix Marseille Univ, INSERM, UMR 1090, Inst MarMaRa,TAGC Theories & Approaches Genom Com, Marseille, France
[8] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Basel, Switzerland
[9] Univ Brasil, Inst Tecnol, Bioengn Program, Sao Paulo, Brazil
[10] Univ Fed Minas Gerais UFMG, Inst Ciencias Biol ICB, Dept Morfol, RNA Syst Biol Lab RSBL, Belo Horizonte, MG, Brazil
来源
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2022年 / 12卷
关键词
Chagas disease; metalloproteinases; MMP; heart failure; cardiac remodeling; cardiomyopathy; fibrosis; HEART-FAILURE; TRYPANOSOMA-CRUZI; EXTRACELLULAR-MATRIX; EXPRESSION; INFARCTION; PROGRESSION; INHIBITORS; MORTALITY; PATHWAYS; FIBROSIS;
D O I
10.3389/fcimb.2022.836242
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chronic Chagas disease (CCC) is an inflammatory dilated cardiomyopathy with a worse prognosis compared to other cardiomyopathies. We show the expression and activity of Matrix Metalloproteinases (MMP) and of their inhibitors TIMP (tissue inhibitor of metalloproteinases) in myocardial samples of end stage CCC, idiopathic dilated cardiomyopathy (DCM) patients, and from organ donors. Our results showed significantly increased mRNA expression of several MMPs, several TIMPs and EMMPRIN in CCC and DCM samples. MMP-2 and TIMP-2 protein levels were significantly elevated in both sample groups, while MMP-9 protein level was exclusively increased in CCC. MMPs 2 and 9 activities were also exclusively increased in CCC. Results suggest that the balance between proteins that inhibit the MMP-2 and 9 is shifted toward their activation. Inflammation-induced increases in MMP-2 and 9 activity and expression associated with imbalanced TIMP regulation could be related to a more extensive heart remodeling and poorer prognosis in CCC patients.
引用
收藏
页数:12
相关论文
共 35 条
  • [31] Circulating matrix metalloproteinase-8 (MMP-8) and MMP-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy
    Marcaccini, Andrea M.
    Novaes, Arthur B., Jr.
    Meschiari, Cesar A.
    Souza, Sergio L.
    Palioto, Daniela B.
    Sorgi, Carlos A.
    Faccioli, Lucia H.
    Tanus-Santos, Jose E.
    Gerlach, Raquel F.
    CLINICA CHIMICA ACTA, 2009, 409 (1-2) : 117 - 122
  • [32] Plasma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with disease severity and C-reactive protein but not with circulating histamine-releasing factors
    Tedeschi, A.
    Asero, R.
    Lorini, M.
    Marzano, A. V.
    Cugno, M.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2010, 40 (06) : 875 - 881
  • [33] Altered pattern of circulating matrix metalloproteinases-2,-9 and tissue inhibitor of metalloproteinase-2 in patients with HCV-related chronic hepatitis. Relationship to histological features
    Bruno, C. M.
    Valenti, M.
    Bertino, G.
    Ardiri, A.
    Consolo, M.
    Mazzarino, C. M.
    Amoroso, A.
    Neri, S.
    PANMINERVA MEDICA, 2009, 51 (04) : 191 - 196
  • [34] Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease
    Navratilova, Zdenka
    Zatloukal, Jaromir
    Kriegova, Eva
    Kolek, Vitezslav
    Petrek, Martin
    RESPIROLOGY, 2012, 17 (06) : 1006 - 1012
  • [35] Role of serum and urine transforming growth factor beta 1, matrix metallopeptidase 9, tissue inhibitor of metalloproteinase 2, and nerve growth factor beta levels and serum neutrophil-to-lymphocyte ratio in predicting recurrence and progression risks in patients with primary non-muscle invasive bladder cancer
    Efiloglu, Ozgur
    Basok, Banu Isbilen
    Turan, Turgay
    Toprak, Tuncay
    Erol, Bulent
    Caskurlu, Turhan
    Yildirim, Asif
    TURKISH JOURNAL OF UROLOGY, 2020, 46 (03): : 206 - 212